Camptothecins in Cancer Therapy
Clinical interest in the camptothecins continues to expand even though this class of topoisomerase I inhibitors has been studied for almost 50 years, and two early generation members of the family have gained FDA approval. In Camptothecins in Cancer Therapy, leading clinicians and researchers critic...
Corporate Author: | SpringerLink (Online service) |
---|---|
Other Authors: | Adams, Val R. (Editor), Burke, Thomas G. (Editor) |
Format: | Electronic eBook |
Language: | English |
Published: |
Totowa, NJ :
Humana Press,
2005.
|
Series: | Cancer Drug Discovery and Development
|
Subjects: | |
Online Access: | Full Text via HEAL-Link |
Similar Items
-
Intraperitoneal Cancer Therapy
Published: (2007) -
Combination Cancer Therapy Modulators and Potentiators /
Published: (2005) -
Death Receptors in Cancer Therapy
Published: (2005) -
Supportive Care in Cancer Therapy
Published: (2009) -
In Vivo Imaging of Cancer Therapy
Published: (2007)